Yael Flamand

A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies

Steffen Boettcher, Peter G. Miller, Rohan Sharma et al. · Science · 2019 · 434 citations · Full text

Life Sciences, Genetics, Oncology +14

Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

Edwin Choy, James E. Butrynski, David C. Harmon et al. · BMC Cancer · 2014 · 174 citations · Full text

Medicine, Oncology, Pharmacology +15

Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

Robert L. Ferris, Yael Flamand, Gregory S. Weinstein et al. · Journal of Clinical Oncology · 2020 · 100 citations

Medicine, Oncology, Surgery +15

Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial

Benjamin H. Kann, Jirapat Likitlersuang, Dennis Bontempi et al. · The Lancet Digital Health · 2023 · 73 citations · Full text

Medicine, Oncology, Radiology +13

Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma

Edwin Choy, Yael Flamand, Sriram Balasubramanian et al. · Cancer · 2014 · 64 citations

Medicine, Oncology, Pharmacology +17